DE3769185D1 - Adsorbate von arzneistoffen an komplexe magnesium-aluminium-silikate und deren herstellung. - Google Patents

Adsorbate von arzneistoffen an komplexe magnesium-aluminium-silikate und deren herstellung.

Info

Publication number
DE3769185D1
DE3769185D1 DE8787810168T DE3769185T DE3769185D1 DE 3769185 D1 DE3769185 D1 DE 3769185D1 DE 8787810168 T DE8787810168 T DE 8787810168T DE 3769185 T DE3769185 T DE 3769185T DE 3769185 D1 DE3769185 D1 DE 3769185D1
Authority
DE
Germany
Prior art keywords
adsorbates
silicates
complex magnesium
aluminum
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787810168T
Other languages
English (en)
Inventor
John Denick
David Peters
Anil K Talwar
Wei Chi Liao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE3769185D1 publication Critical patent/DE3769185D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8787810168T 1986-03-27 1987-03-23 Adsorbate von arzneistoffen an komplexe magnesium-aluminium-silikate und deren herstellung. Expired - Fee Related DE3769185D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/845,101 US4711774A (en) 1986-03-27 1986-03-27 Medicament adsorbates with complex magnesium aluminum silicate and their preparation

Publications (1)

Publication Number Publication Date
DE3769185D1 true DE3769185D1 (de) 1991-05-16

Family

ID=25294400

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787810168T Expired - Fee Related DE3769185D1 (de) 1986-03-27 1987-03-23 Adsorbate von arzneistoffen an komplexe magnesium-aluminium-silikate und deren herstellung.

Country Status (12)

Country Link
US (1) US4711774A (de)
EP (1) EP0239542B1 (de)
JP (1) JPH0676316B2 (de)
AT (1) ATE62405T1 (de)
AU (1) AU574605B2 (de)
CA (1) CA1282328C (de)
DE (1) DE3769185D1 (de)
DK (1) DK167047B1 (de)
ES (1) ES2040760T3 (de)
FI (1) FI871315A (de)
NZ (1) NZ219643A (de)
ZA (1) ZA871660B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894234A (en) * 1984-10-05 1990-01-16 Sharma Shri C Novel drug delivery system for antiarrhythmics
US4894233A (en) * 1984-10-05 1990-01-16 Sharma Shri C Novel drug delivery system for decongestants
US4882158A (en) * 1985-12-20 1989-11-21 Warner Lambert Co. Confectionery delivery system for decongestants
US4882153A (en) * 1985-12-20 1989-11-21 Warner Lambert Co. Confectionery delivery system for antitussives
US4882159A (en) * 1985-12-20 1989-11-21 Warner Lambert Co. Confectionery delivery system for appetite suppressants
US4882157A (en) * 1985-12-20 1989-11-21 Yang Robert K Confectionery delivery system for anti-cholesterolemics
US4882155A (en) * 1985-12-20 1989-11-21 Warner Lambert Co. Confectionery delivery system for antiarrhythmics
US4882151A (en) * 1985-12-20 1989-11-21 Warner Lambert Co. Confectionery delivery system for antihistimines
US4882156A (en) * 1985-12-20 1989-11-21 Warner Lambert Co. Confectionery delivery system for expectorants
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4758424A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation
US4717565A (en) * 1986-03-27 1988-01-05 Warner-Lambert Company Process for the preparation of medicament adsorbates
US4758425A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of antiasthmatics with complex magnesium aluminum silicate and their preparation
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
CA2121435C (en) * 1993-04-16 2002-01-22 Sheila M. Ratnaraj Aqueous pharmaceutical suspension and process for preparation thereof
US5429136A (en) * 1993-04-21 1995-07-04 Devices For Vascular Intervention, Inc. Imaging atherectomy apparatus
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
AU8084594A (en) * 1993-10-28 1995-05-22 Procter & Gamble Company, The Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
SG71877A1 (en) * 1997-12-19 2000-04-18 Johnson & Johnson Consumer Novel powder compositions
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US7935362B2 (en) 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
AU3885201A (en) 1999-09-20 2001-04-24 Mastercare Diet and weight control gum and sucker
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
HUP0400281A3 (en) * 2001-06-22 2009-11-30 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug and process for their preparation
JP2005523262A (ja) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
NZ523128A (en) * 2002-12-12 2006-01-27 Ashmont Holdings Ltd Anthelmintic formulations containing avermectins and or milbemycins
MXPA06001417A (es) 2003-08-04 2006-05-15 Pfizer Prod Inc Composiciones farmaceuticas de adsorbatos de farmacos amorfos y materiales que forman microfases lipofilas.
WO2010046933A2 (en) * 2008-10-22 2010-04-29 Rubicon Research Private Limited Pharmaceutical compositions of taste-masked linezolid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US3248290A (en) * 1962-08-09 1966-04-26 Hoffmann La Roche Antitussive compositions
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US3337402A (en) * 1963-09-03 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical composition
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
US4029797A (en) * 1973-06-20 1977-06-14 Fisons Corporation Process of making cough syrup with masked noscapine
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates

Also Published As

Publication number Publication date
AU574605B2 (en) 1988-07-07
DK153687A (da) 1987-09-28
ZA871660B (en) 1987-08-27
AU7069187A (en) 1987-10-01
ES2040760T3 (es) 1993-11-01
EP0239542B1 (de) 1991-04-10
CA1282328C (en) 1991-04-02
ATE62405T1 (de) 1991-04-15
US4711774A (en) 1987-12-08
JPH0676316B2 (ja) 1994-09-28
DK153687D0 (da) 1987-03-26
EP0239542A3 (en) 1987-12-23
FI871315A0 (fi) 1987-03-25
EP0239542A2 (de) 1987-09-30
DK167047B1 (da) 1993-08-23
FI871315A (fi) 1987-09-28
NZ219643A (en) 1990-03-27
JPS62238215A (ja) 1987-10-19

Similar Documents

Publication Publication Date Title
DE3769185D1 (de) Adsorbate von arzneistoffen an komplexe magnesium-aluminium-silikate und deren herstellung.
DE3767524D1 (de) Arzneistoff-adsorbate mit tensiden und deren herstellung.
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
FR2622799B1 (fr) Forme de dosage pharmaceutique a liberation controlee et procede pour sa preparation
HU891055D0 (en) Ultrasonic contrast materials, process for their preparation and for their use as diagnostical and therapeutical drugs
FR2656337B1 (fr) Electrode generatrice d'oxygene et procede pour sa preparation.
PT91682A (pt) Processo para a preparacao de composicoes farmaceuticas contendo etoposido
PT86572A (de) Polymer-komplexe verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
HU905304D0 (en) Process for producing disubstituted (quinoline-2-il-methoxy)-phenyl-acetic acid derivatives and pharmaceutical preparatives containing them
HU905305D0 (en) Process for producing cyclically substituted (quinoline-2-il-methoxy)-phenyl-acetic acid derivatives and pharmaceutical preparatives containing them
FI883867A (fi) Anvaendning av 2-pyrimidinyl-1 -piperazinderivat.
DE3681334D1 (de) Androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten.
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
DE68921180D1 (de) Apparat für die Verabreichung von Medikamenten für die Veterinärmedizin.
DE3378120D1 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
DE3675378D1 (de) 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
FR2621918B1 (fr) 2',3'-didesoxy-4-thio-uridines, procede de preparation de ces substances et medicaments qui en contiennent
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2643264B1 (fr) Trifluoromethoxy-5 benzimidazolamine-2, procede pour sa preparation et medicaments la contenant
DE3676097D1 (de) 15(r)-5-fluorprostazykline und diese verbindungen enthaltende arzneimittel.
IL85093A0 (en) Pharmaceutical compositions containing retinoids for the treatment of psychotic illnesses
HUT47286A (en) Process for producing benzylaminoaryl-dihydropyridine-lactones and pharmaceutical compositions containing them
SE8705178D0 (sv) Behallare for utportionering av lekemedel i tablettform
ATA263687A (de) Neue imidazo(1,2-a)pyridinderivate und deren herstellung und diese enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee